Elsevier

Journal of Hepatology

Volume 36, Issue 3, March 2002, Pages 328-334
Journal of Hepatology

Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFα-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells

https://doi.org/10.1016/S0168-8278(01)00277-XGet rights and content

Abstract

Background/Aims: Prostaglandin E2 (PGE2) is known to inhibit the lipopolysaccharide (LPS)-induced tumor necrosis factor α (TNFα) formation in Kupffer cells via an increase in cAMP. Four receptor-subtypes have been cloned for PGE2 so far. Two of them, the EP2-receptor and the EP4-receptor are linked to stimulatory Gs-proteins and could mediate the inhibition by PGE2 of TNFα-formation.

Methods: The significance of both receptors for PGE2-dependent inhibition of LPS-induced TNFα-formation was studied using Kupffer cells of mice in which either one of the two receptors had been eliminated by homologous recombination.

Results: The mRNAs of both receptors were expressed in wild type mouse Kupffer cells. Exogenous PGE2 inhibited TNFα-formation in Kupffer cells lacking either EP2-receptor or EP4-receptor to a similar extent as in control cells, however, 10-fold higher PGE2 concentrations were needed for half maximal inhibition in cells lacking the EP4-receptor than in control or EP2-receptor-deficient cells. The response to endogenous PGE2 was blunted in EP4-receptor-deficient mice only and especially after prolonged incubation.

Conclusions: The data indicate, that PGE2 can inhibit TNFα-formation via both the EP2- and the EP4-receptor and that, however, the EP4-receptor appears to be physiologically more relevant in Kupffer cells since it conferred a high affinity response to PGE2.

Introduction

Prostanoids are involved in the regulation of hepatic functions during inflammation. They are released from non-parenchymal liver cells in response to a large array of inflammatory stimuli such as lipopolysaccharide (LPS) [1], zymosan [2], anaphylatoxins [3], [4] and proinflammatory cytokines [5]. Prostanoids modulate hepatocyte functions in a paracrine mode: they influence the glucogenic activity of the hepatocyte by regulation of enzyme activity [6], [7], [8], [9], control of the expression level of key glucogenic enzymes [10] and also indirectly via a modulation of sinusoidal blood flow [11]. Recently, they have been shown to attenuate the IL-6-induced acute phase response of the hepatocyte after an IL-6-dependent expression of previously absent Gs-coupled prostaglandin E2-(PGE2-) receptors [12]. Prostanoids also modulate non-parenchymal cell functions in paracrine and autocrine modes, e.g. thromboxane A2 (TXA2) or prostaglandin F (PGF) contract trans-differentiated hepatic stellate cells [13] while contraction is inhibited by PGE1, PGE2 or prostacyclin (PGI2) [14], [15]. The LPS-induced release of NO [16], [17], reactive oxygen species, or cytokines [18] from Kupffer cells is inhibited by PGE2. For the LPS-induced release of TNFα an autocrine feedback inhibition loop has been shown to exist [19], [20]: LPS and TNFα stimulate the release of PGE2 from Kupffer cells. PGE2 in turn attenuates the TNFα-production via an increase in intracellular cAMP [19]. It is not known so far, which prostanoid-receptor is involved in this signaling chain.

Prostanoids exert their effects on their target cells via heptahelical transmembrane receptors. For the five prostanoids prostaglandin E2 (PGE2), prostaglandin F (PGF), prostaglandin D2 (PGD2), prostacyclin (PGI2) and thromboxane A2 (TXA2) there exist eight types of G-protein-coupled receptors [21]. Four subtypes exist for PGE2, that are coupled to different heterotrimeric G-proteins. The EP1-receptor (EP1-R) couples to Gq, the EP3-receptor (EP3-R) couples to Gi whereas the EP2-receptor (EP2-R) and the EP4-receptor (EP4-R) couple to Gs [22]. These receptors are expressed differentially in the four principal liver cells types, i.e. hepatocytes, Kupffer cells, sinusoidal endothelial cells and hepatic stellate cells [23]. Kupffer cells express both types of Gs-coupled PGE2-R that might possibly confer the PGE2-mediated cAMP-dependent inhibition of TNFα-production. Therefore, the question was addressed, which of the two receptors is part of the feedback inhibition loop. Using Kupffer cell cultures isolated from mice lacking either the EP2-R or the EP4-R it was shown, that both receptors can mediate the PGE2-dependent inhibition of LPS-induced TNFα-formation and can at least partially substitute for each other in Kupffer cells of receptor deficient mice. However, the EP4-R appeared to be physiologically more relevant.

Section snippets

Materials

All materials were from commercial sources and analytical grade. Reverse transcription was primed with oligo(dT) (Pharmacia, Freiburg, Germany). PCR primers were custom synthesized by NAPS (Göttingen, Germany). Pronase E was purchased from Merck (Darmstadt, Germany). Collagenase H and DNase I were from Boehringer (Mannheim, Germany). The ELISA for TNFα was purchased from Pharmingen (San Diego, CA, USA). The radioimmunoassay for PGE2 was from Amersham. ELISA and radioimmunoassay were carried out

Expression of EP2-R and EP4-R in mouse Kupffer cells

It has been shown previously, that both the EP2-R and the EP4-R receptor were expressed in Kupffer cells of the rat [23]. Since there appear to exist differences in prostanoid receptor distribution between rat and mouse, the presence of the EP2-R mRNA and EP4-R mRNA had to be confirmed in mouse Kupffer cells. Further more it was important to show that the disruption of the gene of either one of the Gs-coupled PGE2-receptors did not lead to a compensatory overexpression of the remaining one. By

Discussion

We previously found that in freshly isolated rat Kupffer cells the EP2-R mRNA was more abundant than in any other liver cell type [23]. In addition, the EP2-R mRNA has been shown to be present in monocytes/macrophages of other origin and in monocyte/macrophage cell lines [27], [29] where it was induced to a much larger extent by LPS than the EP4-R [27]. Therefore it was assumed, that mainly the EP2-R might be involved in the regulation of the LPS-induced TNFα-formation in Kupffer cells. In

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft through the Sonderforschungsbereich 402, Teilprojekt B6, the Graduiertenkolleg 335, Fonds der Chemischen Industrie, the Japan Society for the Advancement of Science (fellowship to G.P.P.) and the German Association for the Study of the Liver (fellowship to A.F.).

References (35)

  • V. Blaschke et al.

    Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells

    FEBS Lett

    (1996)
  • M. Grewe et al.

    Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages

    J Hepatol.

    (1994)
  • B.D. Shames et al.

    Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10

    J Surg Res.

    (2001)
  • S.S. Choi et al.

    Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells

    Cell Immunol.

    (1996)
  • G.P. Püschel et al.

    Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a

    Hepatology

    (1993)
  • T. Peters et al.

    Tumor necrosis factor alpha stimulates prostaglandin but not superoxide synthesis in rat Kupffer cells

    Eicosanoids

    (1990)
  • G.P. Püschel et al.

    Glycogenolytic and antiglycogenolytic prostaglandin E2 actions in rat hepatocytes are mediated via different signalling pathways

    Eur J Biochem

    (1993)
  • Cited by (0)

    View full text